AR115203A1 - PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS - Google Patents

PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS

Info

Publication number
AR115203A1
AR115203A1 ARP190100037A ARP190100037A AR115203A1 AR 115203 A1 AR115203 A1 AR 115203A1 AR P190100037 A ARP190100037 A AR P190100037A AR P190100037 A ARP190100037 A AR P190100037A AR 115203 A1 AR115203 A1 AR 115203A1
Authority
AR
Argentina
Prior art keywords
processes
cell
tumor antigens
specific tumor
til products
Prior art date
Application number
ARP190100037A
Other languages
Spanish (es)
Original Assignee
Iovance Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iovance Biotherapeutics Inc filed Critical Iovance Biotherapeutics Inc
Publication of AR115203A1 publication Critical patent/AR115203A1/en

Links

Abstract

La presente proporciona procesos mejorados y/o abreviados y métodos para reprogramar los TIL a fin de preparar poblaciones terapéuticas del TIL con mayor eficacia terapéutica. Estos TIL reprogramados se usan en regímenes de tratamiento terapéuticos.The present provides improved and / or abbreviated processes and methods for reprogramming TILs to prepare therapeutic populations of TIL with greater therapeutic efficacy. These reprogrammed TILs are used in therapeutic treatment regimens.

ARP190100037A 2018-01-08 2019-01-08 PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS AR115203A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862614887P 2018-01-08 2018-01-08

Publications (1)

Publication Number Publication Date
AR115203A1 true AR115203A1 (en) 2020-12-09

Family

ID=74446155

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100037A AR115203A1 (en) 2018-01-08 2019-01-08 PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS

Country Status (1)

Country Link
AR (1) AR115203A1 (en)

Similar Documents

Publication Publication Date Title
MX2020007046A (en) Processes for generating til products enriched for tumor antigen-specific t-cells.
CY1121223T1 (en) Mice EXPRESSING A HUMANIZED MAJOR COMPLIANCE COMPLEX
PE20180673A1 (en) TREATMENT AGAINST CANCER BY MANIPULATING COMENSAL MICROFLORA
CO2017013235A2 (en) Antibodies Against Tumor Necrosis Factor Receptor Ox40 Superfamily Member 4
BR112017018954A2 (en) Use of Ras Protein Mutant Form and Method to Treat Cancer
CO2019010698A2 (en) Peptide vaccines
MX2018008514A (en) Compositions and methods related to multimodal therapeutic cell systems for cancer indications.
CO2017004932A2 (en) Methods for selecting and donor t cell line for adoptive cell therapy
BR112018013731A2 (en) anti-egfr combinations for tumor treatment
AR106144A1 (en) A PROTEIN CONJUGATE THAT INCLUDES PHYSIOLOGICAL POLIPEPTIDES AND AN IMMUNOGLOBULIN FC REGION
GT201200318A (en) ANTIBODIES TO GDF8 HUMAN
AR104664A1 (en) CONJUGATES OF DRUGS WITH ANTIBODIES AGAINST CADHERINE 6 (ANTI-CDH6)
EA201790913A1 (en) TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF STARZED LIVER CELLS WITH THE APPLICATION OF TYPES OF THERAPY REDUCING AMMONIA
EA201991005A1 (en) ANTIBODIES AND POLYPEPTIDES AIMED AGAINST CD127
DOP2018000034A (en) COMBINATIONS OF AN OX40 ANTIBODY AND A TLR4 MODULATOR AND USES OF THE SAME
CY1122746T1 (en) MEDICAL TREATMENTS BASED ON ANAMORELIN
CL2019000846A1 (en) Therapeutic protein.
BR112017025533A2 (en) Method to Treat Cancer in a Human Patient
CL2020001131A1 (en) Oral administration of glp-1 peptide analogs.
CO2020001107A2 (en) Therapeutic modulators of the reverse mode of atp synthase
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA201890623A1 (en) RATIONAL COMBINED THERAPY FOR CANCER TREATMENT
AR115203A1 (en) PROCESSES FOR GENERATING ENRICHED TIL PRODUCTS FOR T-CELL-SPECIFIC TUMOR ANTIGENS
MX2020004771A (en) Methods of treatment and maintenance therapy for bladder cancer using gemcitabine.
EA202190504A1 (en) METHODS FOR TREATMENT OF PSORIASIS